Katz LEL, et al. - The impact of insulin therapy on lipid and inflammatory markers was determined in youth with poorly controlled type 2 diabetes. In youth with type 2 diabetes, worsening dyslipidemia and inflammation over time raised concern regarding premature development of atherosclerosis. In the absence of glycemic control, insulin therapy had a limited benefit.